This article details new guidelines from the World ⁢Health Organization (WHO), ⁤the International Federation of ⁣Gynecology and Obstetrics (FIGO), and the⁣ International Confederation of Midwives (ICM) aimed at preventing, diagnosing, and treating Postpartum Hemorrhage (PPH) - excessive bleeding after ⁢childbirth. PPH is a leading cause⁣ of maternal mortality globally, causing nearly 45,000 deaths annually⁢ and leading to ⁣significant⁢ health impacts even when not fatal.

Key takeaways:

* Earlier Detection is Crucial: The guidelines lower the diagnostic threshold for PPH from⁢ 500mL to 300mL of blood loss when accompanied by abnormal vital signs. this⁤ emphasizes the need for rapid response, as PPH can escalate quickly.

* Improved Diagnostic Tools: Clinicians are advised to use ⁤ calibrated drapes to accurately measure blood loss.

* MOTIVE Bundle for immediate⁣ Action: Upon ⁢diagnosis, the MOTIVE bundle ⁤should be promptly implemented:

⁤ * ⁣ Massage of the⁢ uterus

* Oxytocic drugs

* Tranexamic acid (TXA)

* Intravenous fluids

* Vaginal ⁣and genital tract examination

* Escalation of care if bleeding persists

* Prevention is Key: The guidelines highlight the importance of addressing risk factors like anemia through antenatal and postnatal care, including iron and folate supplementation and, when necessary, intravenous iron transfusions.

* Focus on⁤ Resource-Limited Settings: The guidelines are designed to be impactful even in areas with limited healthcare resources, aiming to improve survival rates and ensure women ⁣can safely return home after childbirth.

The overall message is a call⁣ for proactive readiness, rapid recognition, and swift ⁤response to PPH to significantly reduce maternal mortality and⁢ morbidity.